Should You Buy Baxter International Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Baxter International Inc. (BAX) carries a solid Quality of Company rating of 6.3/10. Trading at $23.71, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 2 of 6 CirclFi valuation models project upside for Baxter International Inc. (BAX) at $23.71 — the model consensus leans bearish, with a Quality Score of 6.3/10 and Value-Trap risk of 48/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Baxter International Inc. (BAX) in 2026?
What Is the Bull Case vs the Bear Case for Baxter International Inc. (BAX)?
| Bull case — $33.98 target (+43.3%) | Bear case — $2.67 target (-88.7%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $33.98 (+43.3%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Value Trap algorithm, the stock shows moderate caution signals, meaning investors should verify that apparent undervaluation isn't masking declining business quality. |
| According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model sees the stock as overvalued with a fair value of $2.67 (-88.7%), suggesting that the market price embeds overly optimistic growth assumptions. | |
| According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +132.0% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
How Does BAX Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: KRMD · BLCO · MMED · TFX · AVTR · RVP · FEMY · MMSI · MDLN · ISRG · RMD
Which Other Stocks Score Like BAX on Quality?
Closest companies to BAX’s Quality of Company score of 6.3/10, across all industries.
- UCTT — Ultra Clean Holdings, Inc. (QOC 6.3) · analysis
- STRR — Star Equity Holdings, Inc. (QOC 6.3) · analysis
- BKKT — Bakkt, Inc. (QOC 6.3) · analysis
- TRCK — Track Group, Inc. (QOC 6.3) · analysis
- MDU — MDU Resources Group, Inc. (QOC 6.3) · analysis
- SFL — SFL Corporation Ltd. (QOC 6.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does BAX Appear In?
So Is Baxter International Inc. (BAX) Worth Buying in 2026?
Our models don't have a clear verdict on Baxter International Inc.. At $23.71 vs. $22.67 median fair value, the median upside of -4.4% masks significant model disagreement (+132.0% spread). With quality at 6.3/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Baxter International Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About BAX Stock?
Should I buy BAX stock right now?
Based on CirclFi's multi-model analysis, 2 of 6 models see upside for BAX at $23.71. The models are divided, which means the investment case depends heavily on your assumptions about Baxter International Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Baxter International Inc.?
Key risks include: an elevated Value Trap score of 48/100, suggesting apparent undervaluation may mask deteriorating fundamentals; limited model coverage (6/13 active), reducing analytical confidence; wide model disagreement (1173% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does BAX compare to its competitors?
Among Medical Instruments & Supplies peers, BAX holds a Quality Score of 6.3/10. Comparable companies include KRMD (QOC 6.5), BLCO (QOC 6.3), MMED (QOC 6.5). The relative ranking helps investors identify whether BAX offers better fundamental quality than alternatives in the same sector.
Is BAX a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BAX's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy BAX at?
CirclFi does not provide target buy prices or price alerts. However, our 6 active models produce fair value estimates ranging from $2.67 to $33.98. At $23.71, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for BAX.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad